The latest developments in life sciences IP litigation

Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada’s post-pandemic economy. Join us for our five-part webinar series that will discuss the latest legal and regulatory developments at all stages of the sector’s complex life cycle.

COVID-19 may have disrupted IP litigation in 2020, but the year has still seen high-impact developments affecting life sciences companies. Our IP regulatory and litigation team Andy Shaughnessy, Eileen McMahon, Karen Townsend and Alexandra Peterson will review the latest developments—including data protection, patent term extension and strategies, as well as important decisions on substantive patent law—all of which may affect life sciences innovation and business models going forward.

9:00 a.m. EDT Webinar opens
9:15 - 10:15 a.m. EDT Presentation

Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.

Click here to register.

Sessions in this series:

• Navigating (and challenging) a changing life sciences regulatory environment
• Life sciences product liability litigation: managing risks and anticipating trends
• The latest developments in life sciences IP litigation
• Life sciences and centralized procurement: navigating the process and responding to RFPs
• Financing life sciences on both sides of the border